Publications

2012

Cooper N, Stasi R, Cunningham-Rundles S, Cesarman E, McFarland JG, Bussel JB. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia. Br J Haematol. 2012;158(4):539-47.
Huang T-, Sahasrabuddhe NA, Kim M-, Getnet D, Yang Y, Peterson JM, et al. Regulation of lipid metabolism by Dicer revealed through SILAC mice. J Proteome Res. 2012;11(4):2193-205.
Métais J-, Winkler T, Geyer JT, Calado RT, Aplan PD, Eckhaus MA, et al. BCL2A1a over-expression in murine hematopoietic stem and progenitor cells decreases apoptosis and results in hematopoietic transformation. PLoS One. 2012;7(10):e48267.
Demichelis F, Setlur SR, Banerjee S, Chakravarty D, Chen JY, Chen CX, et al. Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk. Proc Natl Acad Sci U S A. 2012;109(17):6686-91.
Dunne WM, Westblade LF, Ford B. Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory. Eur J Clin Microbiol Infect Dis. 2012;31(8):1719-26.
Magro CM, A Crowson N, Desman G, Zippin JH. Soluble adenylyl cyclase antibody profile as a diagnostic adjunct in the assessment of pigmented lesions. Arch Dermatol. 2012;148(3):335-44.
Veerappan A, Reid AC, O'Connor N, Mora R, Brazin JA, Estephan R, et al. Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model. Am J Physiol Renal Physiol. 2012;302(1):F192-204.
Berman DM, Bosenberg MW, Orwant RL, Thurberg BL, Draetta GF, Fletcher CD, et al. Investigative pathology: leading the post-genomic revolution. Lab Invest. 2012;92(1):4-8.
Sawai CM, Freund J, Oh P, Ndiaye-Lobry D, Bretz JC, Strikoudis A, et al. Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia. Cancer Cell. 2012;22(4):452-65.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700